As chair of the firm’s multi-disciplinary Managed Care practice, Lindsey Fetzer has a deep understanding of the managed care industry and partners with her clients to provide strategic guidance and solutions in this ever-evolving area. She has extensive experience working with healthcare plans, risk-bearing provider groups, and vendors, in litigation, investigation, and compliance counseling matters. She has conducted dozens of investigations and compliance audits pertaining to issues such as Medicare Advantage risk adjustment, alleged kickback schemes, sales and marketing practices, and quality reporting metrics.
American Bar Association
American Health Law Association (AHLA)
Women’s White Collar Defense Association
Obtained a complete victory for the former vice president of Pilot Flying J who, along with three others, was accused of seeking to defraud customers.
Represented a global healthcare company in relation to an investigation conducted by DOJ and HHS-OIG into alleged violations of the False Claims Act. The alleged false claims involved the manner in which certain negative pressure wound therapy devices were being marketed and distributed as durable medical equipment. Conducted an internal investigation and negotiated a favorable settlement with DOJ, HHS-OIG, and counsel for the relator. No post-settlement oversight was required.
Represented a publicly-traded oilfield services company in an investigation of alleged anti-corruption violations in Africa
Conducted a multi-country FCPA and local law investigation in Southeast Asia for a U.S. company
Advised a multinational company in review of potential anti-money laundering violations
Represented ArthroCare Corporation in a five-year U.S. Department of Justice investigation into allegations of healthcare and securities fraud resulting in a Deferred Prosecution Agreement and no post-settlement monitoring.
Represented a group of diagnostic imaging centers in a U.S. Department of Justice and HHS-OIG investigation alleging False Claims Act violations. Negotiated resolution with no post-investigation monitoring or corporate integrity agreement.
Represented a publicly-traded multinational company in conducting an internal investigation and making voluntary disclosure of FCPA violations to Securities and Exchange Commission (SEC); resulted in formal declination of prosecution by the SEC
Advised a publicly traded U.S. company on anti-corruption due diligence related to the potential acquisition of a U.S. company with an active unresolved DOJ and SEC FCPA investigation
Represented a Fortune 500 company in the oil and gas industry in an internal investigation of alleged FCPA and local law violations related to the company’s operations in Nigeria
Best Lawyers® : Ones To Watch — Health Care Law (2021-2023)
Best Lawyers® : Women In The Law Ones To Watch (2021)
The Wall Street Journal Best Lawyers in DC Ones To Watch (2021)
Washington, D.C. Super Lawyers “Rising Star” (2015-2022)
The Washington Post Top Attorneys Rising Stars in Washington D.C. (2015 & 2020)
Washington and Lee Journal of Civil Rights and Social Justice — Lead Articles Editor